Results 251 to 260 of about 115,987 (377)

Dipeptidyl Peptidase-4 Inhibitor [PDF]

, 2020
openaire   +1 more source

DPP4 in diabetes [PDF]

, 2015
Diana Röhrborn
core   +1 more source

Proteomic profiling of porcine seminal extracellular vesicles reveals potential in vivo fertility biomarkers

Andrology, Volume 14, Issue 2, Page 555-570, February 2026.
Abstract Background Predicting male fertility in farm animals remains a challenge. Seminal plasma (SP) contains a high amount of heterogeneous seminal extracellular vesicles (sEVs), believed involved in reproductive processes and maybe key to understanding male fertility.
Isabel Barranco, Pablo Martínez‐Díaz, Ana Parra, María José Martínez‐Alborcia, Xiomara Lucas, Heriberto Rodríguez‐Martínez, Jordi Roca   +6 more
wiley   +1 more source

Inhibition of dipeptidyl peptidase 9 improves sorafenib sensitivity by inducing ferroptosis in hepatocellular carcinoma. [PDF]

J Cancer Res Clin Oncol
Li Q, Wang Y, Zou J.
europepmc   +1 more source

Administration of a dipeptidyl peptidase IV inhibitor enhances the intestinal adaptation in a mouse model of short bowel syndrome

, 2011
Manabu Okawada, Jens J. Holst, Daniel H. Teitelbaum   +2 more
openalex   +2 more sources

The contributions of dipeptidyl peptidase IV to inflammation in heart failure [PDF]

, 2016
Thiago de Almeida Salles, Camila Zogbi, Thaís Martins de Lima, Camila de Godoi Carneiro, Alexandre Teles Garcez, Hermes Vieira Barbeiro, Ednei Luiz Antônio, Leonardo dos Santos, Alexandre C. Pereira, Paulo José Ferreira Tucci, Daniele de Paula Faria, Francisco García Soriano, Adriana C. C. Girardi   +12 more
openalex   +1 more source

Prognostic Impact of DPP4 Inhibitors on Systemic Drug Therapy for Advanced Kidney Cancer Patients

Cancer Science, Volume 117, Issue 2, Page 468-475, February 2026.
Treatment with DPP4 inhibitors was identified as a favorable prognostic factor in patients with advanced RCC. A more substantial degree of tumor shrinkage was observed in the subgroup of patients who received tyrosine kinase inhibitors or immune checkpoint inhibitors as first‐line therapy.
Shuhei Kamada, Sachi Kitayama, Ryosuke Yamase, Kazuhiro Ikeda, Wataru Sato, Tomokazu Sazuka, Hideki Takeshita, Shinichi Sakamoto, Akihiro Yano, Kuniko Horie, Tomohiko Ichikawa, Satoru Kawakami, Satoshi Inoue   +12 more
wiley   +1 more source

Effects of dipeptidyl peptidase‐4 inhibitors and sulphonylureas on cognitive and physical function in nursing home residents

, 2021
Andrew R. Zullo, Matthew S. Duprey, Robert J. Smith, Roee Gutman, Sarah D. Berry, Medha Munshi, David D. Dore   +6 more
openalex   +2 more sources

Diabetes management in maternally inherited diabetes and deafness (MIDD): A review and a proposed treatment algorithm

Diabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 826-839, February 2026.
Abstract Maternally inherited diabetes and deafness (MIDD) is a mitochondrial disorder usually caused by the variant m.3243A>G in the MT‐TL1 gene. We have proposed that diabetes in MIDD arises from a combination of insulin resistance and impaired β‐cell function that is more likely to occur in the presence of high skeletal muscle heteroplasmy and ...
Ahsen Chaudhry, David M. Thompson, Jean‐Pierre Chanoine   +2 more
wiley   +1 more source

Dipeptidyl Peptidase 4, a Novel Adipokine, Impairs Retinal Microcirculation in Patients With Type 2 Diabetes Mellitus. [PDF]

Invest Ophthalmol Vis Sci
Omae T, Ono S, Kamiya T, Otani S, Yokota H, Nagaoka T.   +5 more
europepmc   +1 more source